Literature DB >> 29686001

Biological Sex Modulates the Adrenal and Blood Pressure Responses to Angiotensin II.

Mohammad Zaki Shukri1, Jia Wei Tan1, Worapaka Manosroi1, Luminita H Pojoga1, Alicia Rivera2, Jonathan S Williams1, Ellen W Seely1, Gail K Adler1, Iris Z Jaffe3, Richard H Karas3, Gordon H Williams1, Jose R Romero4.   

Abstract

The relationship between biological sex and aldosterone on blood pressure (BP) is unclear. We hypothesized that sex would modify the interaction between aldosterone and vascular responses to salt intake and angiotensin II (AngII). To test this hypothesis, in 1592 subjects from the well-controlled Hypertensive Pathotype cohort, we compared responses of women and men to chronic (BP and aldosterone levels in response to dietary salt) and acute (BP, renal plasma flow, and aldosterone responses to AngII infusion) manipulations. Women had a 30% higher salt sensitivity of BP than men (P<0.0005) regardless of age or hypertension status, a greater BP response to AngII, and a 15% greater aldosterone response to AngII on both restricted and liberal salt diets (P<0.005). Furthermore, there was an interaction (P=0.003) between sex and aldosterone on BP response to AngII. Women also had a greater (P<0.01) increment in renal plasma flow in response to AngII than men. To assess potential mechanisms for this sex effect, we compared aldosterone responses to AngII or potassium from rat zona glomerulosa cells and observed greater aldosterone production in female than male zona glomerulosa cells basally and in response to both agonists (P<0.0001). In a rodent model of aldosterone-mediated cardiovascular disease induced by increased AngII and low NO, circulating aldosterone levels (P<0.01), myocardial damage (P<0.001), and proteinuria (P<0.05) were greater in female than male rats despite having similar BP responses. Thus, increased aldosterone production likely contributes to sex differences in cardiovascular disease, suggesting that women may be more responsive to mineralocorticoid receptor blockade than men.
© 2018 American Heart Association, Inc.

Entities:  

Keywords:  aldosterone; angiotensin; blood pressure; receptors, mineralocorticoid; sex

Mesh:

Substances:

Year:  2018        PMID: 29686001      PMCID: PMC6086591          DOI: 10.1161/HYPERTENSIONAHA.117.11087

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  48 in total

1.  Gender differences in the renal response to renin-angiotensin system blockade.

Authors:  Judith A Miller; David Z Cherney; John A Duncan; Vesta Lai; Kevin D Burns; Christopher R J Kennedy; Joseph Zimpelmann; Wei Gao; Daniel C Cattran; James W Scholey
Journal:  J Am Soc Nephrol       Date:  2006-08-16       Impact factor: 10.121

2.  Cardiac damage prevention by eplerenone: comparison with low sodium diet or potassium loading.

Authors:  Diego V Martinez; Ricardo Rocha; Mamiko Matsumura; Eveline Oestreicher; Margarita Ochoa-Maya; Weranuj Roubsanthisuk; Gordon H Williams; Gail K Adler
Journal:  Hypertension       Date:  2002-02       Impact factor: 10.190

Review 3.  Estrogen Signaling in the Adrenal Cortex: Implications for Blood Pressure Sex Differences.

Authors:  Brasilina Caroccia; Teresa M Seccia; Matthias Barton; Gian Paolo Rossi
Journal:  Hypertension       Date:  2016-10       Impact factor: 10.190

4.  Abnormal renal sodium handling in essential hypertension. Relation to failure of renal and adrenal modulation of responses to angiotensin II.

Authors:  N K Hollenberg; T Moore; D Shoback; J Redgrave; S Rabinowe; G H Williams
Journal:  Am J Med       Date:  1986-09       Impact factor: 4.965

Review 5.  Cardiovascular Disease in Women: Clinical Perspectives.

Authors:  Mariana Garcia; Sharon L Mulvagh; C Noel Bairey Merz; Julie E Buring; JoAnn E Manson
Journal:  Circ Res       Date:  2016-04-15       Impact factor: 17.367

6.  Gender difference in blood pressure responses to dietary sodium intervention in the GenSalt study.

Authors:  Jiang He; Dongfeng Gu; Jing Chen; Cashell E Jaquish; Dabeeru C Rao; James E Hixson; Ji-chun Chen; Xiufang Duan; Jian-feng Huang; Chung-Shiuan Chen; Tanika N Kelly; Lydia A Bazzano; Paul K Whelton
Journal:  J Hypertens       Date:  2009-01       Impact factor: 4.844

7.  Response of plasma aldosterone to orthostatism during follicular and luteal phases of the normal menstrual cycle.

Authors:  L M Ruilope; R García-Robles; E Mancheño; F J Rodríguez; A Barrientos; J Torres; J L Radicio; A Oriol-Bosch
Journal:  Rev Esp Fisiol       Date:  1977-12

8.  Estrogen reduces aldosterone, upregulates adrenal angiotensin II AT2 receptors and normalizes adrenomedullary Fra-2 in ovariectomized rats.

Authors:  Miroslava Macova; Ines Armando; Jin Zhou; Gustavo Baiardi; Dmitri Tyurmin; Ignacio M Larrayoz-Roldan; Juan M Saavedra
Journal:  Neuroendocrinology       Date:  2008-08-04       Impact factor: 4.914

9.  Abnormal aldosterone physiology and cardiometabolic risk factors.

Authors:  Anand Vaidya; Patricia C Underwood; Paul N Hopkins; Xavier Jeunemaitre; Claudio Ferri; Gordon H Williams; Gail K Adler
Journal:  Hypertension       Date:  2013-02-11       Impact factor: 10.190

10.  GPER-1 and estrogen receptor-β ligands modulate aldosterone synthesis.

Authors:  Brasilina Caroccia; Teresa M Seccia; Abril Gonzalez Campos; Francesca Gioco; Maniselvan Kuppusamy; Giulio Ceolotto; Eugenia Guerzoni; Francesca Simonato; Sara Mareso; Livia Lenzini; Ambrogio Fassina; Gian Paolo Rossi
Journal:  Endocrinology       Date:  2014-08-28       Impact factor: 4.736

View more
  33 in total

1.  Sexual Dimorphism in Obesity-Associated Endothelial ENaC Activity and Stiffening in Mice.

Authors:  Jaume Padilla; Makenzie L Woodford; Guido Lastra-Gonzalez; Vanesa Martinez-Diaz; Shumpei Fujie; Yan Yang; Alexandre M C Lising; Francisco I Ramirez-Perez; Annayya R Aroor; Mariana Morales-Quinones; Thaysa Ghiarone; Adam Whaley-Connell; Luis A Martinez-Lemus; Michael A Hill; Camila Manrique-Acevedo
Journal:  Endocrinology       Date:  2019-12-01       Impact factor: 4.736

2.  Lack of Suppression of Aldosterone Production Leads to Salt-Sensitive Hypertension in Female but Not Male Balb/C Mice.

Authors:  Jessica L Faulkner; Daisy Harwood; Lily Bender; Lenee Shrestha; Michael W Brands; M Jane Morwitzer; Simone Kennard; Galina Antonova; Eric J Belin de Chantemèle
Journal:  Hypertension       Date:  2018-12       Impact factor: 10.190

3.  Histone demethylase LSD1 deficiency and biological sex: impact on blood pressure and aldosterone production.

Authors:  Yuefei Huang; Pei Yee Ting; Tham M Yao; Tsuyoshi Homma; Danielle Brooks; Isis Katayama Rangel; Gail K Adler; Jose R Romero; Jonathan S Williams; Luminita H Pojoga; Gordon H Williams
Journal:  J Endocrinol       Date:  2019-02-01       Impact factor: 4.286

Review 4.  The endothelial mineralocorticoid receptor: Contributions to sex differences in cardiovascular disease.

Authors:  M Elizabeth Moss; Brigett Carvajal; Iris Z Jaffe
Journal:  Pharmacol Ther       Date:  2019-07-02       Impact factor: 12.310

Review 5.  Obesity and cardiovascular disease in women.

Authors:  Camila Manrique-Acevedo; Bhavana Chinnakotla; Jaume Padilla; Luis A Martinez-Lemus; David Gozal
Journal:  Int J Obes (Lond)       Date:  2020-02-17       Impact factor: 5.095

Review 6.  Female Sex, a Major Risk Factor for Salt-Sensitive Hypertension.

Authors:  Jessica L Faulkner; Eric J Belin de Chantemèle
Journal:  Curr Hypertens Rep       Date:  2020-10-21       Impact factor: 5.369

Review 7.  Mineralocorticoids and Cardiovascular Disease in Females with Insulin Resistance and Obesity.

Authors:  Manav Nayyar; Guido Lastra; Camila Manrique Acevedo
Journal:  Curr Hypertens Rep       Date:  2018-08-14       Impact factor: 5.369

Review 8.  The Na+K+-ATPase Inhibitor Marinobufagenin and Early Cardiovascular Risk in Humans: a Review of Recent Evidence.

Authors:  Michél Strauss; Wayne Smith; Olga V Fedorova; Aletta E Schutte
Journal:  Curr Hypertens Rep       Date:  2019-04-12       Impact factor: 5.369

9.  Autonomic activity and its relationship with the endogenous cardiotonic steroid marinobufagenin: the African-PREDICT study.

Authors:  Michél Strauss; Wayne Smith; Wen Wei; Olga V Fedorova; Aletta E Schutte
Journal:  Nutr Neurosci       Date:  2019-01-07       Impact factor: 4.994

Review 10.  Hypertension: Do Inflammation and Immunity Hold the Key to Solving this Epidemic?

Authors:  Meena S Madhur; Fernando Elijovich; Matthew R Alexander; Ashley Pitzer; Jeanne Ishimwe; Justin P Van Beusecum; David M Patrick; Charles D Smart; Thomas R Kleyman; Justin Kingery; Robert N Peck; Cheryl L Laffer; Annet Kirabo
Journal:  Circ Res       Date:  2021-04-01       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.